TP53mutation in patients with high-risk acute myeloid leukaemia treated with allogeneic haematopoietic stem cell transplantation-Reference-Cited by-同舟云学术

TP53mutation in patients with high-risk acute myeloid leukaemia treated with allogeneic haematopoietic stem cell transplantation

Published:2016-01-13 Issue:6 Volume:172 Page:914-922
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Middeke Jan M.¹,Herold Sylvia¹²,Rücker-Braun Elke¹,Berdel Wolfgang E.³,Stelljes Matthias³,Kaufmann Martin⁴,Schäfer-Eckart Kerstin⁵,Baldus Claudia D.⁶,Stuhlmann Reingard⁷,Ho Anthony D.⁸,Einsele Hermann⁹,Rösler Wolf¹⁰,Serve Hubert¹¹,Hänel Mathias¹²,Sohlbach Kristina¹³,Klesse Christian¹⁴,Mohr Brigitte¹,Heidenreich Falk¹,Stölzel Friedrich¹,Röllig Christoph¹,Platzbecker Uwe¹,Ehninger Gerhard¹,Bornhäuser Martin¹,Thiede Christian¹²,Schetelig Johannes¹¹⁴,

Affiliation:

1. Medizinische Klinik und Poliklinik I; Universitätsklinikum Carl Gustav Carus der TU Dresden; Dresden Germany

2. Deutsches Konsortium für Translationale Krebsforschung Deutsches Krebsforschungszentrum Heidelberg; Heidelberg Germany

3. Medizinische Klinik A; Universitätsklinikum Münster; Münster Germany

4. Robert Bosch Hospital; Stuttgart Germany

5. Klinikum Nord; Nürnberg Germany

6. Charité-Universitätsmedizin Berlin; Berlin Germany

7. Asklepios Klinik St Georg; Hamburg Germany

8. Medizinische Klinik und Poliklinik; Abteilung Innere Medizin V, Hämatologie, Onkologie und Rheumatologie; Universität Heidelberg; Heidelberg Germany

9. Medizinische Klinik und Poliklinik II; Universitätsklinikum Würzburg; Würzburg Germany

10. Medizinische Klinik 5; Universitätsklinikum Erlangen; Erlangen Germany

11. Medizinische Klinik II; Klinikum der J.W. Goethe Universität; Frankfurt Germany

12. Klinikum Chemnitz gGmbH; Klinik für Innere Medizin III; Chemnitz Germany

13. Kliniken für Innere Medizin, Hämatologie/Onkologie und Immunologie; Universitätsklinikum Marburg; Marburg Germany

14. DKMS German Bone Marrow Donor Centre; Clinical Trials Unit; Dresden Germany

Funder

German Cancer Consortium

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.13912/fullpdf

Reference26 articles.

1. Prognostic value of TP53 gene mutations in myelodysplastic syndromes and acute myeloid leukemia treated with azacitidine;Bally;Leukemia Research,2015

2. TET2 mutations predict response to hypomethylating agents in myelodysplastic syndrome patients;Bejar;Blood,2014

3. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet;Döhner;Blood,2010

4. The codon 72 polymorphic variants of p53 have markedly different apoptotic potential;Dumont;Nature Genetics,2003

5. TP53 Codon 72 Polymorphism and Risk of acute leukemia;Dunna;Asian Pacific Journal of Cancer Prevention,2012

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TP53 Mutation-Mediated Immune Evasion in Cancer: Mechanisms and Therapeutic Implications;Cancers;2024-09-03

2. TP53 mutations in myeloid neoplasms: implications for accurate laboratory detection, diagnosis, and treatment;Laboratory Medicine;2024-07-13

3. Lymph node myeloid sarcoma with TP53‑associated myelodysplastic syndrome: A case report;Oncology Letters;2024-05-15

4. Precision Medicine Approaches in Acute Myeloid Leukemia with Adverse Genetics;International Journal of Molecular Sciences;2024-04-11

5. O abordare comparativă a clasificărilor în diagnosticul leucemiilor acute mieloblastice, cu referire la elemente citogenetice, mielodisplazice şi mutaţii ale genei TP53 – OMS, ICC, ELN 202;Oncolog-Hematolog.ro;2024-03-27